Abstract
1 The isolated spontaneously beating atria of the rat, diltiazem (0.01 to 0.1 microM) shifted the atrial rate concentration-response curves to isoprenaline to the right in a non-parallel manner and depressed their maxima. Under the same experimental conditions, (+/-)-propranolol (0.03 to 0.1 microM) behaved as a competitive beta-adrenoceptor antagonist. 2 Whereas (+/-)-propranolol (IC50 = 12 nM) and isoprenaline (IC50 = 0.9 microM) inhibited (-)-[3H]-dihydroalprenolol binding to rat brain membrane preparations, diltiazem failed to do so in concentrations up to 10 microM. 3 Diltiazem but not (+/-)-propranolol, antagonized the positive chronotropic responses to calcium in spontaneously beating rat atria. 4 It is proposed that diltiazem inhibited the tachycardia induced by isoprenaline through an effect on calcium which may be an essential modulator of the sequence of events linking the beta-adrenoceptor activation and heart rate response.
Full text
PDF




Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander R. W., Davis J. N., Lefkowitz R. J. Direct identification and characterisation of beta-adrenergic receptors in rat brain. Nature. 1975 Dec 4;258(5534):437–440. doi: 10.1038/258437a0. [DOI] [PubMed] [Google Scholar]
- Bristow M. R., Green R. D. Effect of diazoxide, verapamil and compound D600 on isoproterenol and calcium-mediated dose-response relationships in isolated rabbit atrium. Eur J Pharmacol. 1977 Oct 1;45(3):267–279. doi: 10.1016/0014-2999(77)90009-7. [DOI] [PubMed] [Google Scholar]
- Levi R., Pappano A. J. Modification of the effects of histamine and norepinephrine on the sinoatrial node pacemaker by potassium and calcium. J Pharmacol Exp Ther. 1978 Mar;204(3):625–633. [PubMed] [Google Scholar]
- Magaribuchi T., Nakajima H., Kiyomoto A. Effects of diltiazem and lanthanum ion on the potassium contracture of isolated guinea pig smooth muscle. Jpn J Pharmacol. 1977 Jun;27(3):333–339. doi: 10.1254/jjp.27.333. [DOI] [PubMed] [Google Scholar]
- Magaribuchi T., Nakajima H., Takenaga H., Kiyomoto A. Effect of diltiazem on the transmembrane potential of isolated guinea pig taenia coli. Jpn J Pharmacol. 1977 Apr;27(2):319–322. doi: 10.1254/jjp.27.319. [DOI] [PubMed] [Google Scholar]
- Nagao T., Sato M., Nakajima H., Kiyomoto A. Studies on a new 1, 5-benzothiazepine derivative (CRD-401). II. Vasodilator actions. Jpn J Pharmacol. 1972 Feb;22(1):1–10. doi: 10.1254/jjp.22.1. [DOI] [PubMed] [Google Scholar]
- Nakajima H., Hoshiyama M., Yamashita K., Kiyomoto A. Electrical and mechanical responses to diltiazem in potassium depolarized myocardium of the guinea pig. Jpn J Pharmacol. 1976 Oct;26(5):571–580. doi: 10.1254/jjp.26.571. [DOI] [PubMed] [Google Scholar]
- Nayler W. G., McInnes I., Swann J. B., Carson V., Lowe T. E. Effect of propranolol, a beta-adrenergic antagonist, on blood flow in the coronary and other vascular fields. Am Heart J. 1967 Feb;73(2):207–216. doi: 10.1016/0002-8703(67)90150-0. [DOI] [PubMed] [Google Scholar]
- Nayler W. G., McInnes I., Swann J. B., Price J. M., Carson V., Race D., Lowe T. E. Some effects of iproveratril (Isoptin) on the cardiovascular system. J Pharmacol Exp Ther. 1968 Jun;161(2):247–261. [PubMed] [Google Scholar]
- Sato M., Nagao T., Yamaguchi I., Nakajima H., Kiyomoto A. Pharmacological studies on a new l,5-benzothiazepine derivative (CRD-401). Arzneimittelforschung. 1971 Sep;21(9):1338–1343. [PubMed] [Google Scholar]
- Toda N. Effects of calcium, sodium and potassium ions on contractility of isolated atria and their responses to noradrenaline. Br J Pharmacol. 1969 Jun;36(2):350–367. doi: 10.1111/j.1476-5381.1969.tb09510.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VAN ROSSUM J. M. Cumulative dose-response curves. II. Technique for the making of dose-response curves in isolated organs and the evaluation of drug parameters. Arch Int Pharmacodyn Ther. 1963;143:299–330. [PubMed] [Google Scholar]
- Yamada K., Shimamura T., Nakajima H. Studies on a new 1,5-benzothiazepine derivative (CRD-401). V. Antiarrhythmic actions. Jpn J Pharmacol. 1973 Jun;23(3):321–328. doi: 10.1254/jjp.23.321. [DOI] [PubMed] [Google Scholar]
